ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EMBT Ember Therapeutics Inc (CE)

0.000001
0.00 (0.00%)
13 Sep 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Ember Therapeutics Inc (CE) USOTC:EMBT OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.00 01:00:00

Embarcadero Technologies, Inc. Stockholders Approve Merger with Thoma Cressey Bravo

22/06/2007 10:00pm

Business Wire


Ember Therapeutics (CE) (USOTC:EMBT)
Historical Stock Chart


From Sep 2019 to Sep 2024

Click Here for more Ember Therapeutics (CE) Charts.
Embarcadero Technologies, Inc. (NASDAQ:EMBT) today announced that Embarcadero’s stockholders have voted to adopt the merger agreement providing for the acquisition of Embarcadero by affiliates of Thoma Cressey Bravo, Inc., a leading private equity investment firm. The results of the vote were reported during a special stockholder meeting held today in San Francisco, California. The number of shares voting to adopt the merger agreement represents approximately 74.3% of the total number of shares outstanding and entitled to vote at the meeting. The proposed merger was announced on April 6, 2007. Embarcadero expects to complete the merger transaction on June 25, 2007. About Embarcadero Technologies Embarcadero Technologies, Inc. (NASDAQ:EMBT) delivers professional grade database tools that companies use to design, develop and manage databases and the data they contain. More than 12,000 customers worldwide and over 90 of the Fortune 100 rely on Embarcadero’s cross-platform tools to reduce complexity, improve productivity and strengthen security. The Company’s flagship database tools include: ER/Studio, DBArtisan, Rapid SQL and Change Manager. Founded in 1993, Embarcadero Technologies is headquartered in San Francisco with offices in Melbourne, Australia, Munich, Germany and Maidenhead, United Kingdom. For more information, visit www.embarcadero.com. Forward-Looking Statements The statements in this press release that are not historical facts are forward-looking statements that involve risks and uncertainties, including risks identified in the Company’s periodic filings with the Securities and Exchange Commission including, but not limited to, those appearing under the caption “Risk Factors” in the Company’s most recent Quarterly Reports on Form 10-Q and Annual Report on Form 10-K. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue relevance on these forward-looking statements, which speak only as of the date hereof. Except as required by law, the Company does not intend to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of anticipated events. Embarcadero, the Embarcadero Technologies logos and all other Embarcadero Technologies product or service names are trademarks of Embarcadero Technologies, Inc. All other trademarks are property of their respective owners. About Thoma Cressey Bravo Thoma Cressey Bravo, Inc. is a leading private equity investment firm with more than 25 years of experience in building successful companies. The firm has invested in many industry sectors and currently specializes in the software, healthcare, business and financial services and consumer industries. In the software industry, Thoma Cressey Bravo’s portfolio of companies represents total earnings in excess of $400 million. The firm currently manages approximately $2 billion of equity capital. For more information on Thoma Cressey Bravo, visit http://www.tcb.com.

1 Year Ember Therapeutics (CE) Chart

1 Year Ember Therapeutics (CE) Chart

1 Month Ember Therapeutics (CE) Chart

1 Month Ember Therapeutics (CE) Chart

Your Recent History

Delayed Upgrade Clock